Cigna Group (CI)
(Delayed Data from NYSE)
$358.58 USD
+9.74 (2.79%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $358.57 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$358.58 USD
+9.74 (2.79%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $358.57 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth C Momentum B VGM
Zacks News
Health Insurers' Courtship Ends on Valentine's Day
by Zacks Equity Research
More than one and a half years of courtship between Anthem Inc. (ANTM) and Cigna Corp. (CI) as well as Aetna Inc. (AET) and Humana Inc. (HUM) ended yesterday.
Cigna Wants Divorce from Anthem Deal, Sues for Nearly $15 Billion
by Madeleine Johnson
On the heels of Aetna's (AET) and Humana's (HUM) announcement, health insurance competitors Cigna (CI) and Anthem (ANTM) also announced that their merger deal is done-zo on Tuesday.
Aetna, Humana Call Off $34 Billion Courtship in Bad Start to Valentine's Day
by Madeleine Johnson
On Tuesday, health insurance giants Aetna (AET) and Humana (HUM) announced that they have called off their merger agreement after a federal court decision struck down the deal as anticompetitive.
Is Cigna (CI) a Great Stock for Value Investors?
by Zacks Equity Research
Cigna (CI) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and U.S. Healthcare Providers iShares ETF
Anthem-Cigna Merger Receives a Blow from Federal Judge
by Zacks Equity Research
As anticipated, the merger between Anthem Inc. (ANTM) and Cigna Corp. (CI) saw the same fate as that of Aetna and Humana which was blocked last month.
Cigna (CI) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Cigna Corp. (CI) reported fourth-quarter 2016 operating net earnings of $1.87 per share, which surpassed the Zacks Consensus Estimate of $1.74. However, earnings remained flat year over year.
Cigna (CI) Beats on Q4 Earnings & Revenues
by Zacks Equity Research
Cigna surpassed the earnings estimate. Our consensus called for earning per share of $1.74, and the company reported earnings of $1.87 per share. Earnings per share were, however, flat year over year.
Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4? (Revised)
by Zacks Equity Research
We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.
Should You Sell Cigna (CI) Before Earnings?
by Zacks Equity Research
Cigna (CI) could be an interesting stock for investors ahead of earnings, as it has a positive ESP and a favorable Zacks Rank.
Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4?
by Zacks Equity Research
We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.
The Hartford (HIG): What's in Store this Earnings Season?
by Zacks Equity Research
The Hartford Financial Services Group, Inc. (HIG) will release fourth-quarter 2016 financial results on Feb 2 after the closing bell.
What's in Store for XL Group (XL) this Earnings Season?
by Zacks Equity Research
XL Group Ltd (XL) is slated to report fourth-quarter 2016 results on Feb 1, after the market closes.
Aetna's Merger with Humana Foiled by Regulators, Stock Down
by Zacks Equity Research
Federal authorities reviewing the proposed Aetna Inc. (AET) and Humana Inc. (HUM) mega merger have now blocked the deal.
Anthem Extends Alliance with Inovalon, Boosts Customer Value
by Zacks Equity Research
Leading U.S.-based Health Maintenance Organization (HMO), Anthem Inc. (ANTM), recently declared a multi-year extension of its partnership with Inovalon Holdings, Inc. (INOV).
Aetna Continues to Grow Business, Merger Remains Uncertain
by Zacks Equity Research
On Dec 27, we issued an updated research report on Aetna Inc. (AET).
Why UnitedHealth (UNH) Stands Tall Amid All the Noise
by Zacks Equity Research
UnitedHealth (UNH) has been able to beat all kinds of industry odds to emerge as a winner.
Aetna CEO Calls Pulling out of ACA Exchanges 'Good Business'
by Zacks Equity Research
Aetna Inc. (AET) recently came under fire for having allegedly pulled out of Affordable Care Act (ACA) exchanges in 11 states, including the areas covered by the Justice Department lawsuit, in a bid to avoid antitrust claims.
Anthem's Membership Growth Impressive, High Debt a Drag
by Zacks Equity Research
On Dec 9, 2016, we have issued an updated research report on Anthem Inc. (ANTM).
6 Insurers Set to Counter Cat Loss with Q2 Earnings Beat
by Tanuka De
insurers in this well-capitalized industry remain well poised on their expanded and diversified product and service portfolio.
Health Insurers Troubled by Election, Public Exchanges
by Zacks Equity Research
U.S. health plans are expected to operate in a lowered margin environment. Some -- especially the smaller ones -- may not survive.